Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury

Armin Buss1, Katrin Pech, Byron A Kakulas

  • 1Department of Neurology, Aachen University Hospital, Aachen, Germany. abuss@ukaachen.de

BMC Neurology
|June 28, 2007
PubMed
Abstract

Insights

Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) are implicated in human spinal cord injury (SCI). MMPs are upregulated post-injury, particularly by macrophages, contributing to inflammation and tissue damage.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Immunology

Background:

  • Matrix metalloproteinases (MMPs) are enzymes degrading extracellular matrix.
  • MMPs play roles in both beneficial and detrimental events following spinal cord injury (SCI).
  • This study investigates MMP and tissue inhibitor of metalloproteinase (TIMP) expression in human spinal cord tissue after SCI.

Purpose of the Study:

  • To examine the expression patterns of specific MMPs and TIMPs in human spinal cord tissue post-SCI.
  • To correlate MMP and TIMP expression with injury type and time course.

Main Methods:

  • Immunohistochemical analysis of post-mortem human spinal cord samples.
  • Inclusion of control and traumatic SCI samples with complete lesions.

Main Results:

  • MMP and TIMP immunoreactivity was low in unlesioned spinal cords.
  • Following SCI, MMP-1, -2, -9, and -12 showed increased expression, primarily in macrophages and astrocytes at different time points.
  • TIMP expression was generally limited, with TIMP-3 showing later induction in astrocytes.

Conclusions:

  • MMP-1, -2, -9, and -12 are involved in post-traumatic events in human SCI.
  • Their expression patterns align with animal studies, suggesting roles in inflammation, protein breakdown, and blood-spinal cord barrier permeability.
  • The lack of corresponding TIMP induction allows MMPs to exert their effects in the injured spinal cord.